GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 296 filers reported holding GUARDANT HEALTH INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,009,861 | -19.8% | 1,990,886 | -3.1% | 0.07% | -16.9% |
| Q2 2023 | $73,572,545 | +119.2% | 2,055,099 | +43.5% | 0.08% | +118.4% |
| Q1 2023 | $33,563,642 | +14733.0% | 1,431,896 | +17112.4% | 0.04% | – |
| Q4 2022 | $226,277 | -44.9% | 8,319 | +8.9% | 0.00% | -100.0% |
| Q3 2022 | $411,000 | +146.1% | 7,640 | +84.6% | 0.00% | – |
| Q2 2022 | $167,000 | -45.2% | 4,139 | -10.1% | 0.00% | – |
| Q1 2022 | $305,000 | -96.6% | 4,603 | -94.9% | 0.00% | -100.0% |
| Q4 2021 | $8,950,000 | -72.4% | 89,489 | -65.5% | 0.01% | -75.0% |
| Q3 2021 | $32,420,000 | -17.3% | 259,338 | -17.8% | 0.04% | -14.3% |
| Q2 2021 | $39,179,000 | -26.0% | 315,470 | -9.0% | 0.04% | -30.0% |
| Q1 2021 | $52,927,000 | +27.2% | 346,725 | +7.4% | 0.06% | +17.6% |
| Q4 2020 | $41,625,000 | +356.6% | 322,971 | +296.0% | 0.05% | +363.6% |
| Q3 2020 | $9,116,000 | – | 81,553 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |